WealthPLAN Partners’s PetMed Express PETS Stock Holding History

WealthPLAN Partners’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-84	Closed	-$1.36K	–	1363
2023 Q1	$1.36K	Buy	+84	New	+$1.58K	﹤0.01%	1175

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

SCM

SG Capital Management Chicago, Illinois $1.21B AUM 70.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WealthPLAN Partners's PETS Position: Q2 2023 in Review

WealthPLAN Partners sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 84 shares — an estimated $1.36K sold.

WealthPLAN Partners first reported a position in PETS in Q1 2023 and held it in 1 quarter. The position peaked at $1.36K in Q1 2023. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

WealthPLAN Partners reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
WealthPLAN Partners sold 84 PetMed Express shares in Q2 2023, an estimated $1.36K.
WealthPLAN Partners first reported a position in PetMed Express in Q1 2023 and held it in 1 quarter.
WealthPLAN Partners's PetMed Express position peaked at $1.36K in Q1 2023.
149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on WealthPLAN Partners's 13F filing for Q2 2023, filed 31 Jul 2023.